Mette Charlot

2.9k total citations
39 papers, 2.1k citations indexed

About

Mette Charlot is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, Mette Charlot has authored 39 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 6 papers in Economics and Econometrics. Recurrent topics in Mette Charlot's work include Antiplatelet Therapy and Cardiovascular Diseases (16 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Heart Failure Treatment and Management (7 papers). Mette Charlot is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (16 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Heart Failure Treatment and Management (7 papers). Mette Charlot collaborates with scholars based in Denmark, United Kingdom and United States. Mette Charlot's co-authors include Gunnar Gislason, Christian Torp‐Pedersen, Peter Riis Hansen, Jesper Lindhardsen, Ole Ahlehoff, Jonas Bjerring Olesen, Lars Køber, Lone Skov, Casper H. Jørgensen and Steen Z. Abildstrøm and has published in prestigious journals such as Circulation, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Mette Charlot

37 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mette Charlot Denmark	20	986	534	426	281	246	39	2.1k
Eric J. Stanek United States	19	609 0.6×	340 0.6×	724 1.7×	128 0.5×	177 0.7×	58	2.1k
Christoph Sinning Germany	30	1.8k 1.9×	306 0.6×	674 1.6×	63 0.2×	253 1.0×	137	3.3k
Meinhard Haltmayer Austria	32	1.3k 1.3×	655 1.2×	785 1.8×	85 0.3×	251 1.0×	62	2.8k
Thao Huynh Canada	26	1.7k 1.7×	69 0.1×	600 1.4×	317 1.1×	74 0.3×	120	2.5k
Robert M. Clare United States	27	2.4k 2.4×	178 0.3×	809 1.9×	45 0.2×	55 0.2×	79	3.0k
Heather Halls Australia	8	460 0.5×	43 0.1×	428 1.0×	700 2.5×	149 0.6×	13	1.6k
Giulia Renda Italy	27	1.9k 1.9×	517 1.0×	746 1.8×	610 2.2×	121 0.5×	111	3.5k
John G. Fort United States	21	749 0.8×	76 0.1×	1.0k 2.4×	1.4k 5.0×	392 1.6×	65	2.6k
Adriana M. Hung United States	30	473 0.5×	123 0.2×	605 1.4×	104 0.4×	55 0.2×	124	3.3k
Anne‐Marie Schjerning Olsen Denmark	22	873 0.9×	55 0.1×	387 0.9×	459 1.6×	145 0.6×	32	1.7k

Countries citing papers authored by Mette Charlot

Since Specialization

Citations

This map shows the geographic impact of Mette Charlot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mette Charlot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mette Charlot more than expected).

Fields of papers citing papers by Mette Charlot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mette Charlot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mette Charlot. The network helps show where Mette Charlot may publish in the future.

Co-authorship network of co-authors of Mette Charlot

This figure shows the co-authorship network connecting the top 25 collaborators of Mette Charlot. A scholar is included among the top collaborators of Mette Charlot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mette Charlot. Mette Charlot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holmvang, Lene, et al.. (2024). Spontaneous coronary artery dissection. Ugeskrift for Læger. 186(48). 1–6. 1 indexed citations

Engstrøm, Thomas, Erik Lerkevang Grove, Charlotte Glinge, et al.. (2023). Bleeding risk and P2Y12 inhibitors in all-comer patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: a single-centre cohort study. European Heart Journal - Cardiovascular Pharmacotherapy. 9(7). 617–626. 6 indexed citations

Christensen, Daniel Mølager, Anne-Marie Schjerning, Mette Charlot, et al.. (2022). Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study. European Heart Journal. 44(6). 488–498. 25 indexed citations

Sehested, T S G, Nicholas Carlson, Thomas Alexander Gerds, et al.. (2019). Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction. European Heart Journal. 40(24). 1963–1970. 55 indexed citations

Kragholm, Kristian, et al.. (2018). Nursing home admission after myocardial infarction in the elderly: A nationwide cohort study. PLoS ONE. 13(8). e0202177–e0202177. 9 indexed citations

Schou, Morten, Christian Torp‐Pedersen, Lars Køber, et al.. (2013). Patient Adherence to Evidence-Based Pharmacotherapy in Systolic Heart Failure and the Transition of Follow-Up from Specialized Heart Failure Outpatient Clinics to Primary Care. European Journal of Heart Failure. 15(6). 671–678. 35 indexed citations

Sørensen, Rikke, Gunnar Gislason, Christian Torp‐Pedersen, et al.. (2013). Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study. BMJ Open. 3(5). e002758–e002758. 156 indexed citations

Charlot, Mette, Lars Nielsen, Jesper Lindhardsen, et al.. (2012). Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study. European Heart Journal. 33(20). 2527–2534. 13 indexed citations

Olsen, Anne‐Marie Schjerning, Emil Loldrup Fosbøl, Jesper Lindhardsen, et al.. (2012). Long-Term Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drug Use According to Time Passed After First-Time Myocardial Infarction. Circulation. 126(16). 1955–1963. 82 indexed citations

10.

Ahlehoff, Ole, Jesper Lindhardsen, Gunnar Gislason, et al.. (2012). Prognosis after percutaneous coronary intervention in patients with psoriasis: a cohort study using Danish nationwide registries. BMC Cardiovascular Disorders. 12(1). 79–79. 9 indexed citations

11.

Olsen, Anne‐Marie Schjerning, Emil Loldrup Fosbøl, Jesper Lindhardsen, et al.. (2011). Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction. Circulation. 123(20). 2226–2235. 243 indexed citations

12.

Olsen, Anne‐Marie Schjerning, Emil Loldrup Fosbøl, Jesper Lindhardsen, et al.. (2011). NSAID TREATMENT IS ASSOCIATED WITH PERSISTENTLY INCREASED RISK OF DEATH IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION: A NATIONWIDE STUDY. Journal of the American College of Cardiology. 57(14). E1027–E1027.

13.

Raunsø, Jakob, Christian Selmer, Jonas Bjerring Olesen, et al.. (2011). Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation. European Heart Journal. 33(15). 1886–1892. 54 indexed citations

14.

Olesen, Jonas Bjerring, Gunnar Gislason, Mette Charlot, et al.. (2011). Calcium-Channel Blockers Do Not Alter the Clinical Efficacy of Clopidogrel After Myocardial Infarction. Journal of the American College of Cardiology. 57(4). 409–417. 38 indexed citations

15.

Ahlehoff, Ole, Gunnar Gislason, Jesper Lindhardsen, et al.. (2011). Psoriasis Carries an Increased Risk of Venous Thromboembolism: A Danish Nationwide Cohort Study. PLoS ONE. 6(3). e18125–e18125. 78 indexed citations

16.

Ahlehoff, Ole, Gunnar Gislason, Casper H. Jørgensen, et al.. (2011). Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. European Heart Journal. 33(16). 2054–2064. 189 indexed citations

17.

Charlot, Mette, Ole Ahlehoff, Mette Lykke Norgaard, et al.. (2010). Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use. Annals of Internal Medicine. 11 indexed citations

18.

Ahlehoff, Ole, Gunnar Gislason, Mette Charlot, et al.. (2010). Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. Journal of Internal Medicine. 270(2). 147–157. 359 indexed citations

19.

Charlot, Mette, Ole Ahlehoff, Casper H. Jørgensen, et al.. (2010). PROTON PUMP INHIBITORS ARE ASSOCIATED WITH CARDIOVASCULAR RISK INDEPENDENT OF CLOPIDOGREL USE IN PATIENTS WITH MYOCARDIAL INFARCTION: A NATIONWIDE PROPENSITY SCORE MATCHED STUDY. Journal of the American College of Cardiology. 55(10). A108.E1005–A108.E1005. 2 indexed citations

20.

Charlot, Mette, Christian Torp‐Pedersen, Nana Valeur, et al.. (2010). Anaemia and Long Term Mortality in Heart Failure Patients: A Retrospective Study. The Open Cardiovascular Medicine Journal. 4(1). 173–177. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact